8-KCorporate ChangesExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Bylaw Amendment (Sep 19, 2014)

Filed September 19, 2014For Securities:BMYCELG-RIBMYMP

Summary

This 8-K filing from Bristol-Myers Squibb Company (BMY) on September 19, 2014, details amendments to the company's bylaws, effective September 16, 2014. These changes are primarily technical and aim to align the company's governance documents with current statutory and case law, reflect best practices, and provide greater clarity. For investors, the most significant aspect is the modernization of procedural rules governing stockholder meetings and board operations, which can impact the ease and flexibility with which the company can conduct these important functions. The amendments allow for greater flexibility in how stockholder meetings are managed, including the possibility of remote participation, postponement, or cancellation. They also clarify procedures for stockholder nominations and proposals, board composition, and the powers of the board and meeting chair. While these changes do not introduce new business strategies or financial performance indicators, they streamline internal processes and governance, which can contribute to more efficient corporate operations.

Key Highlights

  • 1Board of Directors granted explicit authority to postpone, reschedule, or cancel previously scheduled stockholder meetings.
  • 2Stockholder advance notice requirements for nominations and proposals updated to include legally mandated information.
  • 3Clarification provided on director nomination timelines when the board size increases post-nomination deadline.
  • 4Bylaws updated to permit stockholder meetings to be held solely by remote communication.
  • 5Provisions for canceling a special meeting if insufficient stockholder support remains after initial requests are revoked.
  • 6Procedures clarified for determining quorum and conducting business at special meetings, including provisions for absent proposers.
  • 7Notices for stockholder meetings may be delivered via electronic transmission if consented to by the stockholder.

Frequently Asked Questions

The primary purpose of these amendments is to update Bristol-Myers Squibb's bylaws to reflect recent legal developments, incorporate best practices in corporate governance, and provide clearer procedures for various corporate actions, particularly concerning stockholder meetings and board operations.

While the amendments focus on procedural matters, they do not fundamentally alter your core rights as a shareholder. However, they do refine how stockholder meetings are conducted, how advance notice for proposals is handled, and how board matters are managed, which may indirectly influence the process and timing of shareholder engagement.

These bylaw amendments are primarily procedural and do not have direct financial implications. They are designed to improve governance efficiency and clarity rather than to alter the company's financial strategy or reporting.

Yes, the amended bylaws permit the Board of Directors to hold stockholder meetings solely by remote communication, which allows for virtual-only meetings.